Email address
[email protected]Contact number
+852 3658 5362Share profile
Band 2
Provided by Wenseng Pan
Dr. Wenseng “Wendy” Pan, leader of Goodwin’s Life Sciences practice in Asia, specializes in mergers and acquisitions, technology-based transactions, licensing and strategic partnerships as well as financing transactions (including both venture/private equity financings and IPOs), especially in the life sciences and technology industries and in cross-border settings.
She has advised private equity firms in leveraged buy-outs and has represented financial institutions, technology, media and telecoms (TMT), biopharmaceutical, manufacturing, publishing, electronics companies and retail chains in stock and/or cash acquisitions, mergers, tender offers and going-private transactions. Wendy has advised on mergers and acquisitions transactions with an aggregate value over US $10 billion. She also advises on company formation, corporate governance, private and public financings.
J.D., Columbia University School of Law, 1998 (Harlan Fiske Stone Scholar); Ph.D., Chemistry, Columbia University, 1995 (Pegram Award); B.S., Fudan University, 1989 (First Class honors).
Provided by Chambers
Pan Wenseng leads Goodwin's Asia life sciences practice. She offers expertise in a broad range of matters, covering various transactions and strategic collaborations.
Provided by Chambers
I am very impressed by Wenseng's professionalism, knowledge and creative thinking in handling complex issues during negotiations.
Pan Wenseng is business savvy and thoroughly knowledgeable about deal terms and industry norms. She has been a great legal partner for us.
I am very impressed by Wenseng's professionalism, knowledge and creative thinking in handling complex issues during negotiations.
Pan Wenseng is business savvy and thoroughly knowledgeable about deal terms and industry norms. She has been a great legal partner for us.
